Proton Therapy

Proton therapy, or proton beam therapy, is a type of radiation therapy used to treat cancer. At a high energy, the positively charged particles can destroy cancer cells.

Researchers at the University of Wisconsin–Madison will kick off research scanning human subjects with GE Healthcare’s latest generation PCCT prototype in December 2022, representing the first U.S. clinical evaluation site with GE Healthcare’s pure silicon CT detector technology
News | Proton Therapy
UW–Madison To Perform the First U.S. Evaluation of GE Healthcare’s Photon Counting CT Technology with Deep Silicon Detectors

November 25, 2022 — Researchers at the University of Wisconsin–Madison, the first U.S. clinical evaluation site for GE ...

Time November 25, 2022
arrow
The MEVION S250-FIT Proton Therapy System (Photo: Business Wire)
News | Proton Therapy
Mevion Identifies Site for New Compact Proton Therapy System in Development

November 3, 2022 — Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation ...

Time November 03, 2022
arrow
First experience of proton Flash therapy in the clinic appears promising for future clinical trials
News | Proton Therapy
Varian and the Cincinnati Children's/University of Cincinnati Medical Center Proton Therapy Center Announce Promising Results from FAST-01, First-in-Human Clinical Trial of Flash Therapy

October 31, 2022 — Varian, a Siemens Healthineers company, and the Cincinnati Children's/University of Cincinnati ...

Time October 31, 2022
arrow
The MEVION S250-FIT Proton Therapy System (Photo: Business Wire)
News | Proton Therapy
Mevion Introduces New MEVION S250-FIT Proton Therapy System

October 24, 2022 — Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation ...

Time October 24, 2022
arrow
Ultra-high dose-rate radiation treatment found safe and effective for pain relief in small trial of patients with metastatic cancer
News | Proton Therapy
FLASH Radiation Therapy Shows Promise in First-in-human Trial

October 23, 2022 — FLASH radiation treatment – which delivers therapeutic doses of radiation in a fraction of a second – ...

Time October 23, 2022
arrow
Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end imaging and cancer care technologies and services during the 2022 American Society for Radiation Oncology (ASTRO) annual meeting
News | Proton Therapy
Together with Siemens Healthineers, Varian Showcases Technologies and Services Spanning the Full Cancer Care Continuum at ASTRO 2022

October 21, 2022 — Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end ...

Time October 21, 2022
arrow
The first of 396 patients has been enrolled into the PROTECT-trial with the aim of setting new standards for the clinical use of proton radiotherapy in esophageal cancer
News | Proton Therapy
The PROTECT-Trial Consortium Enrolls First Patient into Proton Therapy Study

September 2, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, today ...

Time September 02, 2022
arrow
Ms Preetha Reddy (Executive Vice Chairman AHEL), Dr Prathap Reddy (Chairman AHEL), Olivier Legrain (CEO IBA) & Dr Rakesh Jalali (Clinical Director APCC)
News | Proton Therapy
IBA and Apollo Proton Cancer Centre Sign a Collaboration Agreement to Provide Proton Therapy Training and Education Programs in Asia

August 19, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the ...

Time August 19, 2022
arrow
Under this collaboration, IBA will equip the proton therapy system and the proton gantry treatment room at the Fred Hutchinson Cancer Center with ConformalFLASH research functionality, which will enable preclinical research on FLASH therapy.
News | Proton Therapy
IBA, Fred Hutchinson Cancer Center and the University of Washington engage in a bench-to-bedside research program for FLASH Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

Time August 05, 2022
arrow
The ConformalFLASH Alliance will be the first collaboration platform between academia and industry to bring ConformalFLASH proton therapy to the clinic
News | Proton Therapy
IBA launches the ConformalFLASH Alliance

July 1, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology ...

Time July 01, 2022
arrow
The end goal of ProtOnART is to develop near-real-time adaptive proton therapy
News | Proton Therapy
ProtOnART – A New Consortium for Proton Online Adaptive Radiation Therapy

June 29, 2022 — ProtOnART builds upon the partners’ long-standing research efforts and shared ambition that an online ...

Time June 29, 2022
arrow
Siemens Healthineers and The Ohio State University Wexner Medical Center announced a new alliance, aimed at advancing personalized medicine and improving access to high quality, cost-effective healthcare.
News | Radiology Business
Siemens Healthineers and The Ohio State University Wexner Medical Center Announce Strategic Partnership Focused on Personalized Medicine

June 29, 2022 — Siemens Healthineers and The Ohio State University Wexner Medical Center announced a new alliance, aimed ...

Time June 29, 2022
arrow
Flash therapy delivers radiation at ultra-high dose rates in typically less than one second and is capable of being over 100 times faster compared to conventional radiation therapy
News | Proton Therapy
Varian Receives Investigational Device Exemption (IDE) for Flash Technology Clinical Trial, FAST-02

June 27, 2022 — Varian, a Siemens Healthineers company, announced that the U.S. Food and Drug Administration (FDA) ...

Time June 28, 2022
arrow
NT and H.U.B. representatives signing the Letter of Intent on May 17, 2022 in Brussels, Belgium. From left to right: Prof. Nick Reynaert (H.U.B), Renaud Witmeur (H.U.B), Matthew Copeland (NT), Marko Valjavec (NT), Prof. Dirk Van Gestel (H.U.B), Elizabeth Reczek (NT)
News | Radiation Oncology
Collaboration Offers Cancer Patients a Revolutionary New Treatment Method at Institut Jules Bordet

June 27, 2022 — Neutron Therapeutics, Inc (NT) and the University Hospital of Brussels (H.U.B) today announced that they ...

Time June 28, 2022
arrow
Top 10 ITN content for the Month of May 2022
Feature | Radiology Business | By Melinda Taschetta-Millane
ITN's Top 10 Most-read Content for May

Here is what you and your colleagues found to be most interesting in the field of medical imaging during the month of ...

Time June 01, 2022
arrow
The ultra-compact proton therapy system used in the POC (Photo: Business Wire)
News | Proton Therapy
Successful Proof of Concept for Ultra-compact Proton Therapy System

May 25, 2022 — B dot Medical Inc. and Research Center for Nuclear Physics, Osaka University (RCNP) have conducted a ...

Time May 25, 2022
arrow
Videos | Proton Therapy
VIDEO: First FLASH Proton Therapy Trial Completed in Humans

John C. Breneman, M.D., medical director of the Cincinnati Children's/UC Health Proton Therapy Center, and the principal ...

Time May 16, 2022
arrow
IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces it has received an order from CGN Medical Technologies for a Proteus PLUS[1] proton therapy system to be installed in Yangzhou, China
News | Proton Therapy
IBA Receives Order from CGNNT for a Proteus PLUS System to be Installed in Yangzhou, China

May 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the ...

Time May 05, 2022
arrow
RaySearch Laboratories AB will be showcasing the latest oncology software innovations at ESTRO 2022
News | Radiation Oncology
Latest innovations from RayStation, RayIntelligence and RayCare to be presented at ESTRO 2022

May 5, 2022 — RaySearch Laboratories AB will be showcasing the latest oncology software innovations at ESTRO 2022, to be ...

Time May 05, 2022
arrow
IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology, and the University Medical Center Groningen (UMCG) announce today a four-year research collaboration agreement towards development of a new FLASH irradiation protocol for the treatment of early-stage breast cancer.
News | Women's Health
IBA and UMC Groningen Engage in FLASH Irradiation Research Collaboration for Breast Cancer

April 5, 2022 — IBA (Ion Beam Applications S.A.), a world leader in particle accelerator technology, and the University ...

Time April 05, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now